Year None20202019201820172016 November 2, 2020 Medicenna to Present at Upcoming Scientific and Investor Events in November Go to October 26, 2020 Medicenna Presents Promising Preclinical Data on IL-2 and IL-13 Superkines at the EORTC-NCI-AACR Annual Meeting Go to October 26, 2020 Medicenna Presents Late Breaking Abstract Updating Results from Phase 2b Recurrent GBM Trial at the 36th EORTC-NCI-AACR Meeting Go to October 19, 2020 Medicenna Announces Upcoming Presentations at the EORTC-NCI-AACR Annual Meeting Go to October 15, 2020 Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA) Go to September 30, 2020 Dr. Jack Geltosky Elected To Medicenna Board Of Directors Go to Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Page 4 Page 5 Next page next › Last page last »
October 26, 2020 Medicenna Presents Promising Preclinical Data on IL-2 and IL-13 Superkines at the EORTC-NCI-AACR Annual Meeting Go to
October 26, 2020 Medicenna Presents Late Breaking Abstract Updating Results from Phase 2b Recurrent GBM Trial at the 36th EORTC-NCI-AACR Meeting Go to
October 19, 2020 Medicenna Announces Upcoming Presentations at the EORTC-NCI-AACR Annual Meeting Go to
October 15, 2020 Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA) Go to
